Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 2 study of sufugolix in premenopausal women with endometriosis
2004-003829-28Phase 2Completed
- Sponsor
- Takeda
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sufugolix in endometriosis, sponsored by Takeda. Primary endpoint: Suppression of menses during treatment. Started Feb 2005; status: completed.
02
Drugs
sufugolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2004-003829-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003829-28.